PEPTONIC Medical AB
Peptonic Medical announces appointment of Mikael Svensson as General Manager USA (Cision)

2021-02-23 14:42
Stockholm, Sweden February 23, 2021 - Peptonic Medical AB (publ) (‘Peptonic’ or ‘the company’) has announced the appointment of Mikael Svensson, a strategic and operational leader, to the position of General Manager USA.

Mr. Svensson holds a proven track record of successful business and operational leadership roles in North America and globally. He joins Peptonic from Good Science Beauty where he served as Chief Operations Officer. Prior Mr. Svensson have held international leadership roles with companies such as Johnson & Johnson, Q-Med and Merz.

“We are extremely pleased to welcome Mikael Svensson to Peptonic Medical to lead our US commercialization activities as we continue the rapid growth of our company”, said Johan Inborr, CEO of Peptonic. “Mikael’s strategic perspectives and operational experience from his 15 years in the US will be extremely useful as we leverage our innovative products and expand our footprint in the US.”

Mr. Svensson stated, “I am excited to join an organization that is committed to developing safe and effective products for the $19 billion women's intimate health market, and at a time they are experiencing fast growth and great momentum. I strongly believe in the opportunity for the VagiVital® and Lunette® brands in the US and I am privileged to lead the US commercial development going forward.”


Peptonic Medical - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -